| |
| |
|
| Insider
Information: |
Francois Cedric |
| Relationship: |
Chief Executive Office... |
| City: |
Crestwood |
| State: |
KY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
313,662 |
|
|
Indirect Shares
|
1,721,568 |
|
|
| Direct
Value |
$12,894,645 |
|
|
|
Indirect Value
|
$70,773,660 |
|
|
| Total
Shares |
2,035,230 |
|
|
| Total
Value |
$83,668,305 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
5
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
5
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-5.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -179.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Apellis Pharmaceuticals Inc |
APLS |
Chief Executive Office... |
2024-03-01 |
313,662 |
2024-03-01 |
1,721,568 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
76 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-08-18 |
4 |
AS |
$30.00 |
$46,290 |
D/D |
(1,543) |
1,096,536 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• – – |
2023-02-21 |
4 |
D |
$58.50 |
$93,717 |
D/D |
(1,602) |
1,044,591 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-01-28 |
4 |
D |
$38.59 |
$78,106 |
D/D |
(2,024) |
1,338,463 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2021-02-10 |
4 |
D |
$47.72 |
$120,398 |
D/D |
(2,523) |
1,219,833 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2022-02-10 |
4 |
D |
$47.12 |
$118,884 |
D/D |
(2,523) |
955,940 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-01-29 |
4 |
S |
$64.14 |
$182,345 |
D/D |
(2,843) |
317,624 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-01-27 |
4 |
D |
$52.77 |
$151,925 |
D/D |
(2,879) |
1,036,243 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-08-20 |
4 |
AS |
$30.00 |
$103,710 |
D/D |
(3,457) |
1,093,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-02-10 |
4 |
D |
$51.21 |
$202,689 |
D/D |
(3,958) |
1,032,285 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-02-12 |
4 |
S |
$67.77 |
$268,492 |
D/D |
(3,962) |
313,662 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-09-16 |
4 |
AS |
$26.56 |
$132,949 |
D/D |
(5,000) |
1,021,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-10-15 |
4 |
AS |
$25.59 |
$131,551 |
D/D |
(5,000) |
1,016,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-11-15 |
4 |
AS |
$27.28 |
$136,405 |
D/D |
(5,000) |
1,011,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2019-12-16 |
4 |
AS |
$27.95 |
$139,750 |
D/D |
(5,000) |
1,006,793 |
0 |
- |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-04-15 |
4 |
AS |
$29.77 |
$148,850 |
D/D |
(5,000) |
1,113,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-05-15 |
4 |
AS |
$29.92 |
$149,600 |
D/D |
(5,000) |
1,108,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-06-15 |
4 |
AS |
$30.21 |
$151,050 |
D/D |
(5,000) |
1,103,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-07-15 |
4 |
AS |
$32.12 |
$160,600 |
D/D |
(5,000) |
1,098,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-09-15 |
4 |
AS |
$30.96 |
$154,800 |
D/D |
(5,000) |
1,088,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-10-15 |
4 |
AS |
$34.46 |
$172,300 |
D/D |
(5,000) |
1,083,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-11-16 |
4 |
AS |
$39.38 |
$196,900 |
D/D |
(5,000) |
1,078,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2020-12-15 |
4 |
AS |
$52.16 |
$260,800 |
D/D |
(5,000) |
1,113,079 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-11-21 |
4 |
S |
$48.80 |
$244,000 |
D/D |
(5,000) |
269,655 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2024-01-16 |
4 |
S |
$66.81 |
$524,514 |
D/D |
(7,851) |
333,898 |
0 |
% |
|
| APLS |
Apellis Pharmaceuticals I... |
Chief Executive Officer |
• • – |
2023-01-20 |
4 |
D |
$52.05 |
$492,029 |
D/D |
(9,453) |
1,039,122 |
0 |
- |
|
76 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
